by Chantelle Janse van Rensburg | Nov 26, 2018 | Featured, JEMDSA, News, SAPJ
Empagliflozin proven to improve clinical outcomes in real world practice across a broad spectrum of cardiovascular risk Subsequent to the mandate by the US Food and Drug Administration (FDA) that all new glucose-lowering agents should be tested for...
by Chantelle Janse van Rensburg | Mar 22, 2018 | JEMDSA, News, SAJID, SAPJ
NEW OPEN ACCESS APP TO BOOST CME FOR HEALTH PROFESSIONALS AND MEDICAL STUDENTS The launch of online medical library, Medtalkz, paves the way for health professionals and medical students to stay up to date with the latest research and findings within the medical...
by Chantelle Janse van Rensburg | Nov 14, 2017 | AJCOR, Featured, JEMDSA, Journals, News, PNT, SAFP, SAJAA, SAJCN, SAJGO, SAJID, SAJS, SAPJ, WHSA
INNOVATIVE PHARMA COMPANY LAUNCHES NEW ‘BUG WISE’ APP TO CURB ANTIBIOTIC RESISTANCE Antibiotic resistance (ABR) has increased worldwide, largely because of the overuse and misuse of antibiotic medications, but if left unchecked, experts fear it could claim up to 10...
by admin | Sep 6, 2017 | JEMDSA
Daptomycin belongs to the class of antimicrobial agents known as cyclic lipopeptides. It exhibits bactericidal activity against most Gram positive bacteria through a unique mechanism of action which involves cationic binding to the cytoplasmic cell membrane causing...
